RHAMM, a Receptor for Hyaluronan-Mediated Motility, on Normal Human Lymphocytes, Thymocytes and Malignant B Cells: a Mediator in B cell Malignancy?

References

• Oppenheimer-Marks N., Davis L. S., Lipsky P. E. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to activation status of both the T cell and the endothelial cell. J. Immunol. 1990; 145: 140–148
   PubMed Web of Science ®Google Scholar
• Lawrence M. B., Smith C. W., Eskin S. G., McLntire L. V. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood 1990; 75: 227–237
   PubMed Web of Science ®Google Scholar
• Hemler M. E. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Ann. Rev. Immunol. 1990; 8: 365–400
   PubMed Web of Science ®Google Scholar
• Spertini O. S., Kansas G. S., Munro J. M., Griffin J. D., Tedder T. F. Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature 1991; 349: 691–693
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Turley E. A., Shaw A. R. E., Laderoute M. P., Gallatin W. M., Beckman I. G. R., Zola H. FMC46, a cell protrusion-associated leukocyte adhesion molecule-1 epitope on human peripheral lymphocytes and thymocytes. J. Immunol. 1991; 147: 136–143
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867–869
   PubMed Web of Science ®Google Scholar
• Toole B. P. Hyaluronan and it's binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 1990; 2: 839–844
   PubMed Web of Science ®Google Scholar
• Hardingham T. E., Fosang A. J. Proteoglycans: Many forms and functions. FASEB J. 1992; 6: 861–870
   PubMed Web of Science ®Google Scholar
• Kvist T. N., Finnegan C. V. The distribution of glycosaminoglycans in the axial region of the developing chick embryo. II. biochemical analysis. J. Exp. Zool. 1970; 175: 241–257
   PubMedGoogle Scholar
• Toole B. P. Developmental role of hyaluronate. Conn. Tiss. Res. 1982; 10: 93–100
   PubMed Web of Science ®Google Scholar
• Boudreau N., Rabinovitch M. Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation. Lab. Invest. 1981; 64: 187–199
   Google Scholar
• Toole B. P. Hyaluronan. Cell Biology of the Extracellular Matrix. Plenum Press, New York 1982; 259–259
   Google Scholar
• Turley E. A. Hyaluronan-binding proteins and receptors. Advanced Drug Delivery Reviews 1991; 7: 257–264
   Web of Science ®Google Scholar
• Toole B. P. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 1990; 2: 839–844
   PubMed Web of Science ®Google Scholar
• Hardwick C., Hoare K., Owens R., Hohn H. P., Hook M., Moore M., Cripps V., Austen L., Nance D. M., Turley E. A. Molecular cloning of a novel hyaluronan receptor that mediates tumor motility. J. Cell Biol. 1992; 117: 1343–1350
   PubMed Web of Science ®Google Scholar
• Turley E. A., Bowman P., Kytryk M. A. Effects of hyaluronate binding proteins on cell motile and contact behavior. J. Cell Sci. 1985; 78: 133–145
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Amiot M., Pesando J. M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56: 1057–1062
   PubMed Web of Science ®Google Scholar
• Bazil V., Horejsi V. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor li-gand. J. Immunol. 1992; 149: 747–753
   PubMed Web of Science ®Google Scholar
• Gallatin W. M., Wayner E. A., Hoffman P. A., St John T., Butcher E. C., Carter W. G. Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc. Nat. Acad. Sci., USA 1989; 86: 4654–4658
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Bargatze R. F., de Los Toyos J., Butcher E. C. Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85–95kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell. Biol. 1987; 105: 983–990
   PubMed Web of Science ®Google Scholar
• Thomas L., Byers H. R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronon-coated substrate. J. Cell Biol. 1992; 118: 971–977
   PubMed Web of Science ®Google Scholar
• St John T., Meyer J., Idzerda R., Gallatin W. M. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 1990; 60: 53–61
   PubMed Web of Science ®Google Scholar
• Turley E. A. Hyaluronic acid stimulates protein kinase activity in intact cells and in an isolated protein complex. J. Biol. Chem. 1989; 264: 8951–8955
   PubMed Web of Science ®Google Scholar
• Turley E. A., Austin L., Vandligt K., Clary C. Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell. Biol. 1991; 112: 1041–1047
   PubMed Web of Science ®Google Scholar
• Turley E. A., Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exptl. Cell Res. 1985; 161: 17–28
   PubMed Web of Science ®Google Scholar
• Turley E. A., Belch A. R., Poppema S., Pilarski L. M. Expression and function of a receptor for hyaluronan-mediated motility (RHAMM) on normal and malignant B lymphocytes. Blood 1993; 81: 446–453
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Miszta H., Turley E. A. Regulated expression of a receptor for hyaluronon-mediated motility (RHAMM) on human thymocytes and T cells. J. Immunol. 1993; 150: 4292–4302
   PubMed Web of Science ®Google Scholar
• Pilarski L. M. Antigen-independent adhesive interactions in thymic development: Implications for cell type specific function. Lymphocyte Adhesion Molecules, Y. Shimizu. RG Landes. 1993; 221–248
   Google Scholar
• Pilarski L. M., Jensen G. S. Monoclonal circulating B cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/ Oncology Clinics of North America 1992; 6: 297–322
   PubMed Web of Science ®Google Scholar
• Devreotes P., Zigmond S. Chemotaxis in eu-karyotic cells. Ann. Rev. Cell Biol. 1988; 4: 649–686
   PubMedGoogle Scholar
• Nicolson G. L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Met. Rev. 1988; 7: 143
   PubMed Web of Science ®Google Scholar
• Partin A. W., Isaacs J. T., Treiger B., Coffey D. S. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. Cancer Res. 1988; 48: 6050–6060
   PubMed Web of Science ®Google Scholar
• Turley E. A. Hyaluronan-mediated cell locomotion. Cancer and Met. Rev. 1992; 11: 21–30
   PubMed Web of Science ®Google Scholar
• Romberg L. J., Earp H. S., Turner C. E., Prockop C., Juliano R. L. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of B., integrins. Proc. Natl. Acad. Sci. USA 1991; 88: 8392–8396
   PubMed Web of Science ®Google Scholar
• Stoker M., Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochem. Biophys. Acta 1991; 1072: 81–102
   PubMed Web of Science ®Google Scholar
• Laurent T. C., Fraser J. R. E. Hyaluronan. FASEB J. 1992; 6: 2397–2404
   PubMed Web of Science ®Google Scholar
• Yang B., Zhang L., Turley E. A. Identification of hyaluronan binding motifs in a novel hyaluronan receptor termed RHAMM. J. Biol. Chem. 1993; 268: 8617–8623
   PubMed Web of Science ®Google Scholar
• Markwald R. R., Fitzharris T. P., Bank H., Bernanke D. H. Structural analysis on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev. Biol. 1978; 62: 292–316
   PubMed Web of Science ®Google Scholar
• Turley E. A. Proteoglycans and cell adhesion: their putative role during tumorigenesis. Cancer Met. Rev. 1984; 53: 339–375
   Google Scholar
• Iozzo R. V. Proteoglycans: structure, function, and role in neoplasia. Lab. Invest. 1985; 53: 373–396
   PubMed Web of Science ®Google Scholar
• Hardwick C., Hoare K., Owens R., Hohn H. P., Hook M., Moore D., Cripps V., Austen L., Nance D., Turley E. A. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol. 1992; 117: 1343–1350
   PubMed Web of Science ®Google Scholar
• Haynes B. F., Liao H., Patton K. L. The transmembrane hyalunonate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3: 347–350
   PubMed Web of Science ®Google Scholar
• Miyake K., Underhill C. B., Lesley J., Kincade P. W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 1990; 172: 69–75
   PubMed Web of Science ®Google Scholar
• Culty M., Miyake K., Kincade P. W., Silorski E., Butcher E. C., Underhill C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol. 1990; 111: 2765–2774
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Joensuu H., Klemi P. Prognostic value of lymphocyte homing receptor and S phase fraction in non-hodgkin's lymphoma. Blood 1990; 75: 1549–1556
   PubMed Web of Science ®Google Scholar
• Turley E. A., Austen L., Moore D., Hoare K. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp. Cell Res. 1993; 207: 277–282
   PubMed Web of Science ®Google Scholar
• Turley E. A., Moore D., Hayden L. J. Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells. Biochem. 1987; 26: 2997–3005
   PubMed Web of Science ®Google Scholar
• Klewes L., Turley E. A., Prehm P. The eukaryotic hyaluronate synthase. J. Biochem. 1993; 290: 791–795
   Google Scholar
• Samuel S., Hurta R., Spearman M. A., Wright J. W., Turley E. A., Greenberg A. H. TGF/3 stimulation of cell locomotion is mediated by the hyaluronan receptor RHAMM and hyaluronan. J. Cell Biol. 1993; 123: 749–758
   PubMed Web of Science ®Google Scholar
• Schleiffenbaum B., Spertini O., Tedder T. F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 1992; 119: 229–238
   PubMed Web of Science ®Google Scholar
• Turley E. A., Auersperg N. A hyaluronate binding protein transiently codistributes with p21 k-ras in cultured cell lines. Exptl. Cell Res. 1989; 182: 340–348
   PubMed Web of Science ®Google Scholar
• Turley E. A. The role of a cell-associated hyaluronan-binding protein in fibroblast behavior. CIBA FDN 1989; 143: 121–134
   PubMed Web of Science ®Google Scholar
• Regin C. M., Horwitz A. F. Dynamics of β1 integrin-mediated adhesive contacts in motile fibroblasts. J. Cell Biol. 1992; 119: 1347–1359
   PubMed Web of Science ®Google Scholar
• Bell L., Luthringer D. J., Madri J. A., Warren S. L. Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-srcexpression. J. Clin. Invest. 1992; 89: 315–320
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Gillitzer R., Zola H., Shortman K., Scollay R. Selective expression of CD45 (T200) antigens during human thymocyte differentiation. Eur. J. Immunol. 1988; 19: 589–597
   Web of Science ®Google Scholar
• Deans J. P., Wilkins J. A., Caixia S., Pruski E., Pilarski L. M. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro. J. Immunol. 1991; 147: 4060–4068
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Deans J. P. CD45 isoform transitions on multinegative human thymocytes differentiating in vitro mimic patterns predicted for selective events in vivo. Immunol. Cell Biol. 1993; 71: 289–301
   PubMed Web of Science ®Google Scholar
• Pilarski L. M. Adhesive interactions in thymic development. Does selective expression of CD45 isoforms promote stage-specific microclustering in the assembly of functional adhesive complexes on differentiating T lymphocytes?. Immunol. Cell Biol. 1992; 71: 59–69
   Web of Science ®Google Scholar
• Deans J. P., Serra H. M., Shaw J., Shen Y. J., Torres R. M., Pilarski L. M. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J. Immunol. 1992; 148: 1898–1905
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Yacyshyn B., Jensen G. S., Pruski E., Pabst H. F. Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression. J. Immunol. 1991; 147: 830–837
   PubMed Web of Science ®Google Scholar
• Brecht M., Mayer U., Schlosser E., Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J. 1986; 239: 445–450
   PubMed Web of Science ®Google Scholar
• Spertini O., Freedman A. S., Belvin M. P., Penta A. C., Griffin J. D., Tedder T. F. Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. Leukemia 1991; 5: 300–308
   PubMed Web of Science ®Google Scholar
• Foxwell B. M. J., Mackie A., Ling V., Ryffel B. Identification of the multidrug resistance-related P- glycoprotein as a cyclosporine binding protein. Molec. Pharmacol. 1989; 36: 543–546
   PubMed Web of Science ®Google Scholar
• Higgins C. F. ABC transporters: From microorganisms to man. Ann. Rev. Cell. Biol. 1992; 8: 67–113
   PubMedGoogle Scholar
• Chaudhary P. M., Mechetner E. B., Roninson I. B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80: 2735–2739
   PubMed Web of Science ®Google Scholar
• Gupta S., Kim C. H., Tsuruo T., Gollapudi S. Preferential expression and activity of multidrug resistance gene 1 product (P-Glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J. Clin. Immunol. 1992; 12: 451–458
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Cass C. E., Tsuro T., Belch A. R. Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Current Topics In Microbiol. Immunol. 1992; 182: 177–185
   PubMedGoogle Scholar
• Valverde M. A., Diaz M., Sepulveda F. V., Gill D. R., Hyde S. C., Higgins C. F. Volume-regulated chlorine channels associated with the human multidrug-resistance p-glycoprotein. Nature 1992; 355: 830–833
   PubMed Web of Science ®Google Scholar
• Raymond M., Gros P., Whiteway M., Thomas D. Y. Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 1992; 256: 232–234
   PubMed Web of Science ®Google Scholar
• Scharma R. C., Inoue S., Roitelman J., Schimke R. T., Simoni R. D. Peptide transport by the multidrug resistance pump. J. Biol. Chem. 1992; 267: 5731–5734
   PubMed Web of Science ®Google Scholar
• Gill D. R., Hyde S. C., Higgins C. F., Valverde M. A., Mintenig G. M., Sepulveda F. V. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 1992; 71: 23–32
   PubMed Web of Science ®Google Scholar
• Saeki T., Ueda K., Tanigawara Y., Hon R., Komano T. Human p-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem. 1993; 268: 6011–6080
   Google Scholar
• Danova M., Riccardi A., Ucci G., Luoni R., Giordano M., Mazzini G. Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study. Br. J. Cancer 1990; 62: 781–785
   PubMed Web of Science ®Google Scholar
• Corradini P., Ladetto M., Voena C., Palumbo A., Inghirami G., Knowles D. M., Boccadoro M., Pileri A. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood 1993; 81: 2708–2713
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. S. Staging, kinetics, and flow cytometry of multiple myeloma. Neoplastic Disease of the Blood, P. Wiemik, G. Canellos, R. Kyle, C. Schiffer. Churchill Livingston, New York 1985; Vol. 2: 513–28
   Google Scholar
• Hemler M. E., Elices M. J., Parker C., Takada Y. Structure of the integrin VLA-4 and its cell-cell matrix adhesion functions. Immunol. Rev. 1990; 114: 45–66
   PubMed Web of Science ®Google Scholar
• Gros P., Shustik C. Multidrug resistance: A novel class of membrane-associated transport proteins is identified. Cancer Invest. 1991; 9: 563–569
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Vallera D., Wee S.-L. B lymphocyte regulation of human hematopoiesis. J. Immunol. 1985; 135: 3817–3822
   PubMed Web of Science ®Google Scholar
• Jensen G. S., Mant M. J., Belch A. J., Berensen J. R., Ruether B. A., Pilarski L. M. Selective expression of CD45 isoforms defines CALLA + monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78: 711–719
   PubMed Web of Science ®Google Scholar
• Jensen G. S., Belch A. R., Mant M. J., Ruether B. A., Yacyshyn B. R., Pilarski L. M. Expression of multiple beta-1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am. J. Hematol. 1992; 43: 29–36
   Web of Science ®Google Scholar
• Pilarski L. M., Jensen G. S. Expression of CD45 isoforms (leukocyte common antigen) and adhesion molecules during normal and abnormal B lymphocyte development. Advances in Molecular and Cellular Immunology 1993; IB: 75–117
   Google Scholar
• Chin K.-V., Ueda M., Pastan I., Gottesman M. M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 1992; 255: 459–462
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Belch A. R. Circulating monoclonal B cells expressing P-glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 1994; 83: 724–736
   PubMed Web of Science ®Google Scholar